European Medical Solutions (FRA:AS0) Marketable Securities : €0.96 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is European Medical Solutions Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. European Medical Solutions's Marketable Securities for the quarter that ended in Dec. 2023 was €0.96 Mil.

European Medical Solutions's annual Marketable Securities increased from Dec. 2021 (€0.00 Mil) to Dec. 2022 (€0.41 Mil) and increased from Dec. 2022 (€0.41 Mil) to Dec. 2023 (€0.96 Mil).

European Medical Solutions Marketable Securities Historical Data

The historical data trend for European Medical Solutions's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

European Medical Solutions Marketable Securities Chart

European Medical Solutions Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Marketable Securities

Get a 7-Day Free Trial

0.41

0.96

European Medical Solutions Semi-Annual Data
	Dec13	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Marketable Securities	Get a 7-Day Free Trial															-	-	0.41	0.71	0.96

European Medical Solutions Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

European Medical Solutions (FRA:AS0) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

European Medical Solutions Marketable Securities Related Terms

Thank you for viewing the detailed overview of European Medical Solutions's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

European Medical Solutions (FRA:AS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » European Medical Solutions (FRA:AS0) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

ALIMG:Belgium

Address

7 Rue des Chasseurs Ardennais, Liege, BEL, 4031

Website

https://www.dms-imaging.com

DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

European Medical Solutions (FRA:AS0) Headlines

No Headlines